Medicare’s competitive bidding program cuts ostomy supplies for 1M Americans, exposing systemic flaws in cost-control policies and patient care access

Indigenous healthcare frameworks treat medical supplies as communal resources, not tradable commodities, emphasizing reciprocity and collective well-being over cost-efficiency. The Competitive Bidding Program’s logic of scarcity and competition contradicts Indigenous principles of abundance and shared responsibility, where ostomy supplies would be distributed based on need rather than corporate bids. Additionally, Indigenous disability justice movements highlight how market-based healthcare systems pathologize bodily differences, framing access as a privilege rather than a right.

The Competitive Bidding Program (CBP) traces back to the 2011 Affordable Care Act, but its roots lie in the 1980s neoliberal shift toward privatizing Medicare services, including durable medical equipment (DME). Similar cost-cutting measures in the 1990s led to the collapse of rural home health agencies, disproportionately affecting elderly and disabled populations. Historical parallels include the UK’s Private Finance Initiative (PFI), which privatized hospital infrastructure and later burdened public health systems with unsustainable debt.

In Canada, provincial health systems negotiate bulk purchasing agreements with suppliers to ensure equitable access to ostomy supplies, avoiding the fragmentation seen in the U.S. system. Scandinavian countries integrate ostomy care into broader social welfare models, where supplies are provided free at point of use, reducing administrative burdens on patients. By contrast, Medicare’s CBP creates a patchwork of access that mirrors the inequities of the U.S. healthcare system, where race, income, and geography determine who can afford basic dignity.

Studies show that competitive bidding in Medicare’s DME program has not reliably reduced costs; instead, it has led to reduced supplier participation, especially in rural areas, and increased patient out-of-pocket expenses. Research from the *Journal of the American Medical Association* (2023) found that beneficiaries in competitive bidding areas experienced higher rates of complications due to delayed supply deliveries. The faulty assumption—that market competition ensures quality and affordability—ignores the reality of information asymmetry and supplier consolidation.

Artists and disability advocates have used visual and performance art to expose the dehumanization of patients under market-driven healthcare, such as the *Ostomy Art Project*, which centers the lived experiences of those affected by supply shortages. Spiritual traditions like Ubuntu (Southern Africa) and *Manaakitanga* (Māori) frame healthcare as a sacred duty, contrasting with the transactional ethos of Medicare’s CBP. These perspectives highlight how cost-cutting policies strip care of its moral and communal dimensions, reducing patients to economic variables.

If unchecked, the CBP could expand to other essential supplies (e.g., insulin, wheelchairs), further commodifying health necessities and deepening disparities. Scenario modeling suggests that integrating patient-centered procurement—such as community health worker networks—could reduce costs while improving outcomes. Future policy must account for climate-related supply chain disruptions, which could exacerbate shortages in rural and marginalized communities.

Disabled and low-income Americans, particularly Black and Indigenous communities, are disproportionately affected by ostomy supply restrictions, as they lack the resources to navigate appeals or purchase supplies privately. The CBP’s reliance on large suppliers often excludes small, local providers run by and for marginalized populations, such as Black-owned DME businesses. Patient advocacy groups like the *United Spinal Association* have documented how bureaucratic hurdles disproportionately burden those with the least social capital.